339.30
price up icon0.56%   1.88
 
loading
前日終値:
$337.42
開ける:
$340.26
24時間の取引高:
1.47M
Relative Volume:
0.56
時価総額:
$183.22B
収益:
$37.30B
当期純損益:
$7.80B
株価収益率:
23.60
EPS:
14.3793
ネットキャッシュフロー:
$8.60B
1週間 パフォーマンス:
+3.98%
1か月 パフォーマンス:
-1.91%
6か月 パフォーマンス:
+0.52%
1年 パフォーマンス:
+24.79%
1日の値動き範囲:
Value
$338.40
$343.80
1週間の範囲:
Value
$320.96
$343.80
52週間の値動き範囲:
Value
$267.83
$391.29

Amgen Inc Stock (AMGN) Company Profile

Name
名前
Amgen Inc
Name
セクター
Healthcare (1108)
Name
電話
(805)447-1000
Name
住所
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA
Name
職員
31,500
Name
Twitter
@amgen
Name
次回の収益日
2026-04-30
Name
最新のSEC提出書
Name
AMGN's Discussions on Twitter

Compare AMGN vs LLY, JNJ, ABBV, MRK, AZN

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
AMGN icon
AMGN
Amgen Inc
339.30 182.21B 37.30B 7.80B 8.60B 14.38
LLY icon
LLY
Lilly Eli Co
1,065.00 928.88B 72.25B 25.28B 10.37B 27.78
JNJ icon
JNJ
Johnson Johnson
234.34 557.82B 96.36B 21.04B 17.80B 8.6488
ABBV icon
ABBV
Abbvie Inc
215.70 378.98B 62.82B 3.60B 19.98B 2.0274
MRK icon
MRK
Merck Co Inc
122.41 286.20B 65.51B 8.93B 14.12B 3.5532
AZN icon
AZN
Astrazeneca Plc
187.03 294.27B 60.48B 10.40B 8.05B 3.3297

Amgen Inc Stock (AMGN) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-04-21 開始されました Canaccord Genuity Hold
2026-03-10 開始されました Jefferies Hold
2026-02-20 開始されました Barclays Equal Weight
2026-01-20 ダウングレード Bernstein Outperform → Mkt Perform
2026-01-07 再開されました UBS Buy
2025-12-05 アップグレード Erste Group Hold → Buy
2025-11-24 再開されました Truist Hold
2025-11-13 開始されました Scotiabank Sector Outperform
2025-09-03 再開されました Raymond James Mkt Perform
2025-05-20 再開されました Guggenheim Neutral
2025-04-22 再開されました Cantor Fitzgerald Neutral
2024-12-10 再開されました BofA Securities Underperform
2024-11-15 開始されました Wolfe Research Peer Perform
2024-11-14 開始されました Citigroup Neutral
2024-10-17 開始されました Bernstein Outperform
2024-10-14 ダウングレード Truist Buy → Hold
2024-09-27 開始されました Cantor Fitzgerald Overweight
2024-08-07 ダウングレード Wells Fargo Overweight → Equal Weight
2024-05-03 アップグレード Barclays Underweight → Equal Weight
2024-05-03 アップグレード William Blair Mkt Perform → Outperform
2024-03-28 再開されました Raymond James Mkt Perform
2024-02-07 ダウングレード Leerink Partners Outperform → Market Perform
2023-12-21 アップグレード Daiwa Securities Neutral → Buy
2023-12-19 アップグレード BMO Capital Markets Market Perform → Outperform
2023-12-12 アップグレード RBC Capital Mkts Sector Perform → Outperform
2023-11-09 開始されました Deutsche Bank Hold
2023-11-02 アップグレード Truist Hold → Buy
2023-10-20 再開されました JP Morgan Neutral
2023-10-17 再開されました Morgan Stanley Equal-Weight
2023-10-11 再開されました BofA Securities Neutral
2023-09-06 開始されました HSBC Securities Buy
2023-04-24 繰り返されました Oppenheimer Outperform
2023-03-13 アップグレード Wells Fargo Equal Weight → Overweight
2023-02-13 繰り返されました Truist Buy
2022-11-18 開始されました Credit Suisse Underperform
2022-10-31 ダウングレード Barclays Equal Weight → Underweight
2022-10-11 アップグレード Morgan Stanley Equal-Weight → Overweight
2022-05-23 開始されました SVB Leerink Mkt Perform
2022-02-09 繰り返されました Barclays Equal Weight
2022-02-09 繰り返されました Jefferies Buy
2022-02-09 繰り返されました Morgan Stanley Equal-Weight
2022-02-09 繰り返されました Oppenheimer Outperform
2022-02-09 繰り返されました Wells Fargo Equal Weight
2022-01-05 ダウングレード BofA Securities Buy → Neutral
2021-12-09 再開されました Wells Fargo Equal Weight
2021-12-06 開始されました Goldman Buy
2021-11-19 開始されました BMO Capital Markets Market Perform
2021-09-23 ダウングレード Daiwa Securities Outperform → Neutral
2021-09-07 ダウングレード Morgan Stanley Overweight → Equal-Weight
2020-12-29 開始されました Daiwa Securities Buy
2020-10-28 開始されました UBS Neutral
2020-10-26 アップグレード Raymond James Mkt Perform → Outperform
2020-10-12 アップグレード Truist Hold → Buy
2020-10-09 ダウングレード Bernstein Outperform → Mkt Perform
2020-10-09 ダウングレード Truist Buy → Hold
2020-10-08 ダウングレード Raymond James Outperform → Mkt Perform
2020-04-15 再開されました Guggenheim Neutral
2020-03-31 開始されました Wolfe Research Peer Perform
2020-03-30 アップグレード Raymond James Mkt Perform → Outperform
2020-03-05 アップグレード BofA/Merrill Neutral → Buy
2020-02-27 開始されました Barclays Equal Weight
2020-01-31 ダウングレード Robert W. Baird Neutral → Underperform
2020-01-21 アップグレード Evercore ISI In-line → Outperform
2019-12-24 開始されました Raymond James Mkt Perform
2019-12-17 再開されました Morgan Stanley Overweight
2019-11-12 開始されました SunTrust Buy
2019-11-05 アップグレード Cantor Fitzgerald Neutral → Overweight
2019-10-17 再開されました BofA/Merrill Neutral
2019-08-19 ダウングレード Mizuho Buy → Neutral
2019-05-23 アップグレード Citigroup Neutral → Buy
すべてを表示

Amgen Inc (AMGN) 最新ニュース

pulisher
03:38 AM

Axxcess Wealth Management LLC Raises Position in Amgen Inc. $AMGN - MarketBeat

03:38 AM
pulisher
03:32 AM

Amgen Inc. $AMGN Shares Acquired by Americana Partners LLC - MarketBeat

03:32 AM
pulisher
02:32 AM

Amgen Inc. stock (US0311621009): weight-loss data and obesity ambitions move into focus - AD HOC NEWS

02:32 AM
pulisher
01:07 AM

Amgen (NASDAQ:AMGN) Upgraded by Wall Street Zen to "Buy" Rating - MarketBeat

01:07 AM
pulisher
May 22, 2026

Amgen Inc. (NASDAQ: AMGN) Stock Trades Near $330 as Japan Drug Safety Crisis Raises Concerns - foreignpolicyjournal.com

May 22, 2026
pulisher
May 22, 2026

Amgen Inc. stock (US0311621009): obesity data, Horizon deal and pipeline put focus back on the biote - AD HOC NEWS

May 22, 2026
pulisher
May 22, 2026

Keudell Morrison Wealth Management Makes New Investment in Amgen Inc. $AMGN - MarketBeat

May 22, 2026
pulisher
May 22, 2026

Rx Rundown: Parabilis Medicines, Boston Scientific, Amgen and more - Medical Marketing and Media

May 22, 2026
pulisher
May 22, 2026

Global Retirement Partners LLC Purchases 5,691 Shares of Amgen Inc. $AMGN - MarketBeat

May 22, 2026
pulisher
May 22, 2026

A Look At Amgen (AMGN) Valuation As Tavneos Safety Concerns And Withdrawal Requests Escalate - Yahoo Finance

May 22, 2026
pulisher
May 22, 2026

Amgen Inc. Stock 12‑Month Price Target Cut to $352.32, Implies 4% Upside - TradingView

May 22, 2026
pulisher
May 21, 2026

Amgen stock (US0311621009): Q1 revenue tops estimates, CFO change keeps debt in focus - AD HOC NEWS

May 21, 2026
pulisher
May 21, 2026

Amgen Shareholders Reaffirm Board, Pay and Auditors - The Globe and Mail

May 21, 2026
pulisher
May 21, 2026

Amgen’s ‘boomerang’ CFO reaps $12.5M in cash, retention bonuses - CFO Dive

May 21, 2026
pulisher
May 21, 2026

Amgen CFO Change Puts Focus On Debt, Growth And Capital Discipline - simplywall.st

May 21, 2026
pulisher
May 21, 2026

Amgen Drug Gets New Warnings in Japan After Patient Deaths - WSJ

May 21, 2026
pulisher
May 21, 2026

CytomX Therapeutics to Present at Upcoming June Investor Conferences - GlobeNewswire Inc.

May 21, 2026
pulisher
May 21, 2026

The Escalator: Amgen, CG Life, Cosette Pharmaceuticals and more - Medical Marketing and Media

May 21, 2026
pulisher
May 21, 2026

IFP Advisors Inc Has $3.92 Million Stake in Amgen Inc. $AMGN - MarketBeat

May 21, 2026
pulisher
May 21, 2026

Liquidity Mapping Around (AMGN) Price Events - Stock Traders Daily

May 21, 2026
pulisher
May 21, 2026

Amgen Inc. (AMGN): Navellier’s Long-Term Pick on Pipeline Strength and Sales Growth - Insider Monkey

May 21, 2026
pulisher
May 21, 2026

ABN Amro Investment Solutions Acquires 13,431 Shares of Amgen Inc. $AMGN - MarketBeat

May 21, 2026
pulisher
May 21, 2026

Amgen's CFO resigns – a successor has been named - medwatch.com

May 21, 2026
pulisher
May 21, 2026

Amgen Inc. (NASDAQ:AMGN) Given Consensus Rating of "Hold" by Analysts - MarketBeat

May 21, 2026
pulisher
May 20, 2026

Amgen Inc. 8-K Filing May 2026: Executive Compensation Approval and Shareholder Voting Results - Minichart

May 20, 2026
pulisher
May 20, 2026

Declaration of Voting Results by Amgen Inc - marketscreener.com

May 20, 2026
pulisher
May 20, 2026

As Griffith retires, Dittrich returns to Amgen, takes CFO role - biocentury.com

May 20, 2026
pulisher
May 20, 2026

The Story of Maridebart Cafraglutide (MariTide) - Amgen

May 20, 2026
pulisher
May 20, 2026

Amgen’s Approach to AI-Enabled Clinical Development - Amgen

May 20, 2026
pulisher
May 20, 2026

Amgen : Approach to AI-Enabled Clinical Development - marketscreener.com

May 20, 2026
pulisher
May 20, 2026

Amgen Advances Xaluritamig Trial in Hard-to-Treat Prostate Cancer - TipRanks

May 20, 2026
pulisher
May 20, 2026

Amgen Inc. stock (US0311621009): Weight-loss drug data and guidance update keep investors on alert - AD HOC NEWS

May 20, 2026
pulisher
May 20, 2026

Amgen, bidding adieu to CFO, lures Galderma exec with hefty $12.4M bonus - Fierce Pharma

May 20, 2026
pulisher
May 20, 2026

Argus Adjusts Price Target on Amgen to $375 From $400, Maintains Buy Rating - marketscreener.com

May 20, 2026
pulisher
May 20, 2026

PNC Financial Services Group Inc. Has $343.34 Million Stock Position in Amgen Inc. $AMGN - MarketBeat

May 20, 2026
pulisher
May 20, 2026

Amgen announces CFO Peter Griffith retiring - The Pharma Letter

May 20, 2026
pulisher
May 20, 2026

Cullen Frost Bankers Inc. Cuts Stake in Amgen Inc. $AMGN - MarketBeat

May 20, 2026
pulisher
May 20, 2026

Fairtree Asset Management Pty Ltd Acquires New Stake in Amgen Inc. $AMGN - MarketBeat

May 20, 2026
pulisher
May 20, 2026

Harvest Portfolios Group Inc. Lowers Stock Position in Amgen Inc. $AMGN - MarketBeat

May 20, 2026
pulisher
May 20, 2026

Fideuram Intesa Sanpaolo Private Banking S.P.A. Takes Position in Amgen Inc. $AMGN - MarketBeat

May 20, 2026
pulisher
May 20, 2026

Amgen Inc. $AMGN Shares Bought by Banque Cantonale Vaudoise - MarketBeat

May 20, 2026
pulisher
May 20, 2026

Atle Fund Management AB Has $7.17 Million Stake in Amgen Inc. $AMGN - MarketBeat

May 20, 2026
pulisher
May 20, 2026

AMGN Technical Analysis | Trend, Signals & Chart Patterns | AMGEN INC (NASDAQ:AMGN) - ChartMill

May 20, 2026
pulisher
May 19, 2026

Standing Bone Strong: Introducing a New Awareness Symbol for Osteoporosis - Amgen

May 19, 2026
pulisher
May 19, 2026

Amgen Inc. (AMGN) Announces CFO Transition with Retirement of Pe - GuruFocus

May 19, 2026
pulisher
May 19, 2026

Amgen Earnings Call Highlights Growth Amid Headwinds - TipRanks

May 19, 2026
pulisher
May 19, 2026

Amgen stock (US0311621009): CFO succession and analyst reaction keep focus on biotech heavyweight - AD HOC NEWS

May 19, 2026
pulisher
May 19, 2026

Amgen says CFO Peter Griffith to retire, names Dittrich as successor - WTAQ

May 19, 2026
pulisher
May 19, 2026

Amgen stock (US0311621009): FDA data and pipeline updates in focus - AD HOC NEWS

May 19, 2026
pulisher
May 19, 2026

Amgen (AMGN) Announces CFO Transition with Peter Griffith's Reti - GuruFocus

May 19, 2026
pulisher
May 19, 2026

Amgen (AMGN) Announces CFO Transition as Peter Griffith Retires - GuruFocus

May 19, 2026

Amgen Inc (AMGN) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
NVO NVO
$44.96
price up icon 1.28%
$134.36
price up icon 2.96%
PFE PFE
$25.90
price down icon 0.19%
NVS NVS
$152.01
price up icon 0.16%
AZN AZN
$187.03
price down icon 1.43%
大文字化:     |  ボリューム (24 時間):